Insider Information: Nexstim Plc launches an unsecured convertible bond offering of up to EUR 750,000
Company Announcement, Helsinki, 25 June 2024 at 9 AM (EEST) Insider Information: Nexstim Plc launches an unsecured convertible bond offering...
Brain
Roche’s OCREVUS subcutaneous administration approved by European Commission, as first and only twice-a-year injection for relapsing and primary progressive multiple sclerosis
OCREVUS subcutaneous (SC) injection offers a new, 10-minute administration of OCREVUS with comparable efficacy and safety to intravenous infusion (IV)...
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Could Be an Important Weapon to Fight Bird Flu H5N1, Says NanoViricides
SHELTON, CT / ACCESSWIRE / June 24, 2024 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a clinical stage global leader...
Acasti Announces Year-End 2024 Financial Results, Provides Business Update
Patient Enrollment in Pivotal STRIVE-ON Phase 3 Safety Trial for GTX-104 On-Track for Potential NDA Submission in 1H Calendar 2025Projected...
Clene Presents Preliminary Data for CNM-Au8® as a Potential Treatment for Rett Syndrome
CNM-Au8 demonstrated neuroprotective effects in an in vitro model of Rett Syndrome, a rare pediatric neurodevelopmental diseaseCNM-Au8 also demonstrated rescue...
Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2
– Preclinical data for ARV-393 presented at the European Hematology Association 2024 Annual Congress showed anti-tumor activity in models of...
Gemina Laboratories Commences Trading on the OTCQB Market in the United States
Gemina Laboratories (OTCQB: GLABF), (CSE: GLAB), (FRA: 817) expands investor reach to U.S. by posting shares on OTCQB. VANCOUVER, BC...
The Multiple Sclerosis Association of America (MSAA) Commemorates 15 Years of Highlighting Artists with MS
CHERRY HILL, N.J., June 20, 2024 /PRNewswire/ -- The Multiple Sclerosis Association of America (MSAA) is proud to recognize 15...
Aidoc’s New AI Patient Management Technology Boosts Clinic Volumes and Elevates Patient Care
Yale New Haven Health unveils impact data during the 2024 Vascular Annual Meeting (VAM), showing Aidoc AI's ability to support...
Media Cybernetics Unveils Next-Generation Image-Pro AI Software for Microscope-Based Research and Inspection
ROCKVILLE, Md., June 20, 2024 /PRNewswire/ -- Media Cybernetics proudly announces the release of Image-Pro® AI, a groundbreaking image analysis software...
Astellas Announces Sponsored Research Agreement with UMass Chan Medical School
- Collaboration to focus on gene therapy research for the treatment of ultra-rare disease NORTHBROOK, Ill., June 20, 2024 /PRNewswire/...
HealthTech Connex Awarded $1 Million from The Government of Canada to Revolutionize Concussion Detection and Recovery
The NeuroCatch Platform, a subsidiary of HealthTech Connex, offers an objective evaluation of cognitive function, delivered in minutes at the...
Can AI learn like us?
COLD SPRING HARBOR, N.Y., June 20, 2024 /PRNewswire/ -- It reads. It talks. It collates mountains of data and recommends...
The Siegel Rare Neuroimmune Association Creates First-Ever Online Micro-Course for People With Rare Neuroimmune Disorders
The online learning program reflects organization's dedication to empowering individuals and families affected by these conditions with knowledge and supportPOWELL,...
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
Parkinson’s Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients’ Own Autologous Replacement NeuronsSOLANA BEACH, Calif., June...
Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and Dementia
HOUSTON, TEXAS, June 20, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced...
Microbot Medical Partners with Brigham and Women’s Hospital for Its Pivotal Human Clinical Trial
Following FDA Approval to Commence the Clinical Trial, an Official Site Initiation Has Taken Place as Preparation for Patient Enrollment...
Oragenics, Inc. Announces NYSE American Acceptance of Plan of Compliance
SARASOTA, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal...
Lupus Research Alliance Awards Lupus Insight Prize to Two Trailblazers in CAR T Cell Therapy
Drs. Marko Radic and Georg Schett Honored at FOCIS 2024 Meeting SAN FRANCISCO, June 20, 2024 /PRNewswire/ -- The Lupus...
Rutherrin(R) Demonstrates Complete Response in Lung Cancer Preclinically
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...